Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females
Clinical trial NCT06893796 · COMPLETED
Trial details
- NCT number
- NCT06893796
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2025-05-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.